Covestor Ltd - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 226 filers reported holding SAGE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
Covestor Ltd ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$07
+133.3%
0.00%
Q1 2024$03
-25.0%
0.00%
Q4 2023$0
-100.0%
4
-92.0%
0.00%
-100.0%
Q3 2023$150
+900.0%
0.00%
Q2 2023$0
-100.0%
5
-98.2%
0.00%
-100.0%
Q1 2023$12
-45.5%
285
-49.5%
0.01%
+11.1%
Q4 2022$22564
+7957.1%
0.01%
Q3 2022$070.0%0.00%
Q2 2022$0
-100.0%
7
-93.3%
0.00%
-100.0%
Q1 2022$3,000
-40.0%
104
-3.7%
0.00%
-71.4%
Q4 2021$5,0001080.01%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Third Rock Ventures, LLC 9,773,073$490,901,00052.36%
Ghost Tree Capital, LLC 240,000$12,056,0002.17%
EcoR1 Capital, LLC 112,455$5,649,0001.88%
New Leaf Venture Partners, L.L.C. 43,770$2,199,0001.49%
AlpInvest Partners B.V. 12,195$613,0001.15%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 595,443$29,909,0000.97%
APEX CAPITAL, LLC 190,000$9,544,0000.69%
OAK RIDGE INVESTMENTS LLC 385,770$19,377,0000.43%
Lombard Odier Asset Management (USA) Corp 92,089$4,626,0000.37%
SPHERA FUNDS MANAGEMENT LTD. 65,724$3,301,0000.34%
View complete list of SAGE THERAPEUTICS INC shareholders